Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...

The FDA granted priority review to a new drug application for sunvozertinib as an oral treatment for certain patients with ...

Source: Science Source Images The IFM2017-03 trial, which showed positive results with a dexamethasone-sparing regimen, is “one of the most practice-changing” studies presented at ASH 2024 ...

These numbers are closer to our results; however, dexamethasone was again not allowed in the Seynaeve trial, and the patients received a higher mean cisplatin dose (72 mg/m 2). The current study ...

The patients were randomized 1:2 to treatment either with the Rd regimen of 28-day cycles of lenalidomide (25 mg/d, 21/28) and dexamethasone (20 mg once weekly) or with the dexamethasone-sparing ...

Patients in the BVd arm received belantamab mafodotin at 2.5 mg/kg every 3 weeks, given in combination with bortezomib and dexamethasone ... visual acuity to 20/50 or worse, and 2% had a decrease ...

The successor to the MG ZS EV electric SUV appears set to be known as the 2025 MG S5 EV in Australia when the new model arrives in showrooms next year. It is set to be available with three battery ...

This means that losing 20 lbs may take 10 to 20 weeks. To lose weight, people will likely need to follow a healthy diet and get regular exercise. Some popular diets are effective initially but ...